MedPath

DEVATIS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

TGA:4

Drug Approvals

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.5 mg capsule blister pack (458466)

Product Name
FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.5 mg capsule blister pack
Approval Date
Jul 10, 2025
TGA

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.25 mg capsule blister pack (458465)

Product Name
FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.25 mg capsule blister pack
Approval Date
Jul 10, 2025
TGA

AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216347)

Product Name
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Approval Date
Dec 15, 2014
TGA

DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216346)

Product Name
DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Approval Date
Dec 15, 2014
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.